date:Apr 29, 2014
Corbion has reported positive net sales and EBITDA growth in Q1 2014 despite significant negative exchange rate effects. Organic sales growth was 3.0% due to strong growth in the Biochemicals segment. EBITDA before one-off costs at constant currencies increased by 3.2 million or 13.6% compared to Q1 2013. Expenditure on RD rose significantly.
Reported sales were 182.7m compared with the year-ago quarters 180.5m.
I am pleased with our EBITDA growth versus the first quarter of last year, despite